NCT06241183View on ClinicalTrials.gov

Famotidine and Antacids for Treatment of Dyspepsia

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
DyspepsiaGERDAcid Reflux
Interventions
DRUG

Intravenous Famotidine

Patients in this group will receive 20mg IV Famotidine.

DRUG

Oral Maalox/ Mylanta

Patients in this group will receive 30 ml Maalox/ Mylanta.

Trial Locations (1)

11794

RECRUITING

Stony Brook University Hospital, Stony Brook

All Listed Sponsors
lead

Stony Brook University

OTHER